Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Okada

Showing results (51-60 of 277) with videos related to

Pageof 28
Sort By:
Diabetes Technology & Therapeutics|July 18, 2022
Association Between Time in Range and Postprandial Glucose Contribution Rate in Non-Insulin-Treated Type 2 Diabetes Patients: Inverse Correlation of Time in Range with Postprandial Glucose Contribution RateFumi Uemura, Yosuke Okada, Keiichi Torimoto, et al.
Internal Medicine (Tokyo, Japan)|November 3, 2016
Excess Visceral Adipose Tissue Worsens the Vascular Endothelial Function in Patients with Type 2 Diabetes MellitusAkira Kurozumi, Yosuke Okada, Tadashi Arao, et al.
Journal of UOEH|June 20, 2003
Role of cyclooxygenase-2 in bone resorptionYosuke Okada, Carol Pilbeam, Lawrence Raisz, et al.
Clinical Calcium|June 6, 2007
[Vascular injury by glucocorticoid; involvement of apoptosis of endothelial cells]Yosuke Okada, Takahisa Tanikawa, Takeshi Iida, et al.
Journal of UOEH|September 11, 2022
[A Case of Reactive Hypoglycemia Exacerbated Before Menstruation Improved by the Use of Continuous Glucose Monitoring]Momo Saito, Yosuke Okada, Keiichi Torimoto, et al.
Scientific Reports|January 8, 2022
Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective studyKenichi Tanaka, Yosuke Okada, Akemi Tokutsu, et al.
Journal of Diabetes Investigation|July 1, 2020
Case of autoimmune polyendocrine syndrome type 3 complicated with anti-N-methyl-D-aspartic acid-receptor encephalitisAkira Kurozumi, Yosuke Okada, Kosuke Nishio, et al.
Diabetology & Metabolic Syndrome|April 16, 2021
Relationship between glycemic intraday variations evaluated in continuous glucose monitoring and HbA1c variability in type 2 diabetes: pilot studyAkemi Tokutsu, Yosuke Okada, Keiichi Torimoto, et al.
Internal Medicine (Tokyo, Japan)|December 17, 2025
Development of Marine-Lenhart Syndrome During the Course of Acromegaly. A Case ReportMomo Saito, Yosuke Okada, Fumi Uemura, et al.
Diabetology & Metabolic Syndrome|August 9, 2017
Early effects of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes: study based on continuous glucose monitoringKeiichi Torimoto, Yosuke Okada, Kenji Koikawa, et al.
Pageof 28

Showing results (51-60 of 277) with videos related to

Sort By:
Pageof 28
Diabetes Technology & Therapeutics|July 18, 2022
Association Between Time in Range and Postprandial Glucose Contribution Rate in Non-Insulin-Treated Type 2 Diabetes Patients: Inverse Correlation of Time in Range with Postprandial Glucose Contribution RateFumi Uemura, Yosuke Okada, Keiichi Torimoto, et al.
Internal Medicine (Tokyo, Japan)|November 3, 2016
Excess Visceral Adipose Tissue Worsens the Vascular Endothelial Function in Patients with Type 2 Diabetes MellitusAkira Kurozumi, Yosuke Okada, Tadashi Arao, et al.
Journal of UOEH|June 20, 2003
Role of cyclooxygenase-2 in bone resorptionYosuke Okada, Carol Pilbeam, Lawrence Raisz, et al.
Clinical Calcium|June 6, 2007
[Vascular injury by glucocorticoid; involvement of apoptosis of endothelial cells]Yosuke Okada, Takahisa Tanikawa, Takeshi Iida, et al.
Journal of UOEH|September 11, 2022
[A Case of Reactive Hypoglycemia Exacerbated Before Menstruation Improved by the Use of Continuous Glucose Monitoring]Momo Saito, Yosuke Okada, Keiichi Torimoto, et al.
Scientific Reports|January 8, 2022
Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective studyKenichi Tanaka, Yosuke Okada, Akemi Tokutsu, et al.
Journal of Diabetes Investigation|July 1, 2020
Case of autoimmune polyendocrine syndrome type 3 complicated with anti-N-methyl-D-aspartic acid-receptor encephalitisAkira Kurozumi, Yosuke Okada, Kosuke Nishio, et al.
Diabetology & Metabolic Syndrome|April 16, 2021
Relationship between glycemic intraday variations evaluated in continuous glucose monitoring and HbA1c variability in type 2 diabetes: pilot studyAkemi Tokutsu, Yosuke Okada, Keiichi Torimoto, et al.
Internal Medicine (Tokyo, Japan)|December 17, 2025
Development of Marine-Lenhart Syndrome During the Course of Acromegaly. A Case ReportMomo Saito, Yosuke Okada, Fumi Uemura, et al.
Diabetology & Metabolic Syndrome|August 9, 2017
Early effects of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes: study based on continuous glucose monitoringKeiichi Torimoto, Yosuke Okada, Kenji Koikawa, et al.
Pageof 28